Original Article

Relations Between Residential Proximity to EPA-Designated Toxic Release Sites and Diffuse Large B-Cell Lymphoma Incidence

Authors: Catherine Bulka, MPH, Loretta J. Nastoupil, MD, Jean L. Koff, MD, Leon Bernal-Mizrachi, MD, Kevin C. Ward, PhD, Jessica N. Williams, BS, A. Rana Bayakly, MPH, Jeffrey M. Switchenko, PhD, Lance A. Waller, PhD, Christopher R. Flowers, MD, MS

Abstract

Objectives: Examining the spatial patterns of diffuse large B-cell lymphoma (DLBCL) incidence and residential proximity to toxic release locations may provide insight regarding environmental and sociodemographic risk factors.

Methods: We linked and geocoded cancer incidence data for the period 1999–2008 from the Georgia Comprehensive Cancer Registry with population data from the US Census and the Environmental Protection Agency’s Toxics Release Inventory. We conducted cluster analyses and constructed Poisson regression models to assess DLBCL incidence as a function of mean distance to the toxic release sites.

Results: In total, 3851 incident DLBCL cases occurred among adults residing in Georgia between 1999 and 2008. Significant focal clustering was observed around 57% of ethylene oxide sites, 5% of benzene sites, 9% of tetrachloroethylene sites, 7% of styrene sites, 10% of formaldehyde sites, 5% of trichloroethylene sites, and 10% of all release sites. Mean distance to sites was significantly associated with DLBCL risk for all chemicals.

Conclusions: Proximity to Toxics Release Inventory sites can be linked to increased DLBCL risk as assessed through focal clustering and Poisson regression, and confirmatory studies using geospatial mapping can aid in further specifying risk factors for DLBCL.

 

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Bulka C, Nastoupil LJ, McClellan W, et al. Residence proximity to benzene release sites is associated with increased incidence of non-Hodgkin lymphoma. Cancer 2013;119:3309-3317.
 
2. Shenoy PJ, Malik N, Nooka A, et al. Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States. Cancer 2011;117:2530-2540.
 
3. Shenoy PJ, Malik N, Sinha R, et al. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States. Clin Lymphoma Myeloma Leuk 2011;11:498-506.
 
4. Bollati V, Baccarelli A, Hou L, et al. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res 2007;67:876-880.
 
5. De Roos AJ, Davis S, Colt JS, et al. Residential proximity to industrial facilities and risk of non-Hodgkin lymphoma. Environ Res 2010;110:70-78.
 
6. James W, Jia C, Kedia S. Uneven magnitude of disparities in cancer risks from air toxics. Int J Environ Res Public Health 2012;9:4365-4385.
 
7. Perlin SA, Wong D, Sexton K. Residential proximity to industrial sources of air pollution: interrelationships among race, poverty, and age. J Air Waste Manag Assoc 2001;51:406-421.
 
8. Morrens B, Bruckers L, Hond ED, et al. Social distribution of internal exposure to environmental pollution in Flemish adolescents. Int J Hyg Environ Health 2012;215:474-481.
 
9. Hun DE, Siegel JA, Morandi MT, et al. Cancer risk disparities between Hispanic and non-Hispanic white populations: the role of exposure to indoor air pollution. Environ Health Perspect 2009;117:1925-1931.
 
10. Flowers CR, Fedewa SA, Chen AY, et al. Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States. Cancer Epidemiol Biomarkers Prev 2012;21:1520-1530.
 
11. Flowers CR, Shenoy PJ, Borate U, et al. Examining racial differences in diffuse large B-cell lymphoma presentation and survival. Leuk Lymphoma 2013;54:268-276.
 
12. Environmental Protection Agency. Factors to consider when using Toxics Release Inventory data. https://www.epa.gov/toxics-release-inventory-tri-program/factors-consider-when-using-toxics-release-inventory-data. Updated September 2, 2015. Accessed August 5, 2016.
 
13. US Census Bureau. Introduction to Census 2000 data products. http://www.census.gov/prod/2001pubs/mso-01icdp.pdf. Accessed July 28, 2016.
 
14. Abouyabis AN, Shenoy PJ, Lechowicz MJ, et al. Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States. Leuk Lymphoma 2008;49:2099-2107.
 
15. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 13 Registries Research Data, November 2010 Submission (1973-2008) <Katrina/Rita Population Adjustment> Linked to County Attributes-Total US Bethesda, MD: National Cancer Institute 2009.
 
16. Morton LM, Turner JJ, Cerhan JR, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007;110:695-708.
 
17. ESRI. Common questions. http://www.esri.com/training/main/common-questions. Accessed August 5, 2016.
 
18. Waller LA, Gotway C. Applied Spatial Statistics for Public Health Data. New York:Wiley , 2004.
 
19. Kleinbaum DG, Kupper LL, Nizam A, et al. Applied Regression Analysis and Other Multivariable Methods. Thomson Brooks/Cole:Independence, KY , 2008.
 
20. Hayes RB, Yin SN, Dosemeci M, et al. Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine-National Cancer Institute Benzene Study Group. J Natl Cancer Inst 1997;89:1065-1071.
 
21. Rinsky RA, Hornung RW, Silver SR, et al. Benzene exposure and hematopoietic mortality: a long-term epidemiologic risk assessment. Am J Ind Med 2002;42:474-480.
 
22. Kipen HM, Cody RP, Crump KS, et al. Hematologic effects of benzene: a thirty-five year longitudinal study of rubber workers. Toxicol Ind Health 1988;4:411-430.
 
23. Ramis R, Diggle P, Boldo E, et al. Analysis of matched geographical areas to study potential links between environmental exposure to oil refineries and non-Hodgkin lymphoma mortality in Spain. Int J Health Geogr 2012;11:4.
 
24. Linos A, Blair A, Gibson RW, et al. Leukemia and non-Hodgkin’ lymphoma and residential proximity to industrial plants. Arch Environ Health 1991;46:70-74.
 
25. Morton LM, Wang SS, Cozen W, et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood 2008;112:5150-5160.
 
26. Pasqualucci L, Trifonov V, Fabbri G, et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 2011;43:830-837.
 
27. Lohr JG, Stojanov P, Lawrence MS, et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci U S A 2012;109:3879-3884.
 
28. Love C, Sun Z, Jima D, et al. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet 2012;44:1321-1325.
 
29. Morin RD, Mungall K, Pleasance E, et al. Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing. Blood 2013;122:1256-1265.
 
30. Zhang J, Grubor V, Love CL, et al. Genetic heterogeneity of diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A 2013;110:1398-1403.
 
31. Colt JS, Rothman R, Severson RK, et al. Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma. Blood 2009;113:1899-1905.
 
32. Rothman N, Skibola CF, Wang SS, et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 2006;7:27-38.
 
33. Wheeler DC, De Roos AJ, Cerhan JR, et al. Spatial-temporal analysis of non-Hodgkin lymphoma in the NCI-SEER NHL case-control study. Environ Health 2011;10:63.
 
34. Chang CM, Schroeder JC, Olshan AF, et al. A case-control study of tobacco use and other non-occupational risk factors for lymphoma subtypes defined by t(14; 18) translocations and bcl-2 expression. Cancer Causes Control 2010;21:1147-1154.
 
35. Fisher SG, Fisher RI. The epidemiology of non-Hodgkin’ lymphoma. Oncogene 2004;23:6524-6534.
 
36. Friedberg JW, Fisher RI. Diffuse large B-cell lymphoma. Hematol Oncol Clin North Am 2008;22:941-952.
 
37. Hartge P, Devesa SS. Quantification of the impact of known risk factors on time trends in non-Hodgkin’ lymphoma incidence. Cancer Res 1992;52( 19 Suppl ):5566s-5569s.
 
38. Lim U, Freedman DM, Hollis BW, et al. A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. Int J Cancer 2009;124:979-986.
 
39. Zahm SH, Morton LM, Bernstein L, et al. Re: hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma, author response. Carcinogenesis 2008;29:1084-1085.
 
40. Zhang Y, Sanjose SD, Bracci PM, et al. Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma. Am J Epidemiol 2008;167:1321-1331.
 
41. Zhang L, McHale CM, Rothman N, et al. Systems biology of human benzene exposure. Chem Biol Interact 2010;184:86-93.